Intersolar Europe: Agrivoltaics – Harvesting Solar Power
The world population is growing, as is the demand for food. To tackle the climate crisis, the world needs both agricultural land and surfaces for the deployment of photovoltaics (PV). In line with the zeitgeist, agricultural PV brings together both worlds: agriculture and renewable power generation. Solar modules built over fields can transport us into the new energy world faster, all the while protecting important agricultural yields. This is why Intersolar Europe – The world’s leading exhibition for the solar industry – will be focusing on the topic. Together with the French-German Office for Energy Transition (DFBEW), Intersolar Europe will be presenting new business models and best practices from France and Germany. Agricultural PV is also on the agenda of the Intersolar Europe Conference. Intersolar Europe will be held as part of The smarter E Europe, the continent’s largest platform for the energy industry, from June 14 to 16, 2023 in Munich.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230427005413/en/
Trend topic Agrivoltaics will be presented at Intersolar Europe 2023 in Munich, Germany. (Photo: Solar Promotion GmbH)
Agrivoltaics is currently trending. Agrivoltaics projects are demonstrating how the generation of solar power and agriculture can go hand in hand and benefit from each other and how the conflict over available surfaces can be cleverly solved.
Renewable electricity for decentralized self-consumption is a great opportunity for agricultural operations adding solar installations to their assets. It allows them to use the renewable power generated on their land and reduce their bills for grid-supplied electricity. If they have excess electricity, they can sell it, which provides an additional source of income. What’s more, agricultural PV installations can boost resilience and increase the yield of agricultural operations because solar modules offer protection against heavy rain, hail or drought for fruit and special crops.
Europe recognizes potential
In many European countries, more and more farmers and political decision-makers are recognizing the potential of agricultural PV. Italy, for instance, recently passed new regulations that determine which agricultural PV installations are eligible for funding from a government incentive program with a scope of 1.1 billion euros, giving a boost to innovative agricultural PV installations. While Germany is testing agricultural PV in combination with the cultivation of apples, for example, in Gelsdorf in Rhineland Palatinate, France has started installing solar modules over rows of vines.
With tractor and tracker – trend towards dual use
Covering crops with raised solar modules – as French winegrowers are doing now – is particularly interesting because it is favorable for winegrowing, as well as for fruit, berries or herbs, and any plants that prefer partial shade. Furthermore, solar roofs can replace conventional hail netting or polytunnels, and they protect the crops from drying out.
Integrating solar installations into agriculture opens up many areas of application. Free-standing solar installations on fields and meadows can also be equipped with trackers that follow the course of the sun, which increases the yield compared with conventional, fixed modules, by around 20 percent. The solar panels can also be moved out of the way of any working agricultural machinery.
Agri PV: Hot topic at Intersolar Europe
To learn all there is to know about solar power generation in agriculture, join us at Intersolar Europe. The session “Agricultural PV in France and Germany: Potential, Business Models and Best Practice” (Agri-PV in Deutschland und Frankreich: Potenziale, Geschäftsmodelle und Best Practices) on June 15 at 3:20pm CEST at the Intersolar Forum will be presenting an extensive overview of solutions and applications that already work. An even more hands-on experience will be offered by many exhibitors, such as BayWa r.e. AG, Fraunhofer Institute for Solar Energy Systems (ISE), Next2Sun GmbH, Goldbeck Solar GmbH, SunFarming GmbH and many more. The program of the Intersolar Europe Conference will be looking into agricultural PV one day before the start of the exhibition itself. Experts will be discussing the potential of solar power in agriculture.
Intersolar Europe will be held from June 14–16, 2023 as part of The smarter E Europe 2023 at Messe München. Over 85,000 visitors from all corners of the globe are expected to attend. More than 2,200 exhibitors across 17 exhibition halls covering 180,000 square meters will be waiting for them.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230427005413/en/
Contact information
Peggy Zilay
Spokesperson
The smarter E Europe
+49 7231 58598-240
zilay@solarpromotion.com
Juliane Heermeier
Account Manager
+49 151 41482446
juliane.heermeier@fischerappelt.de
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 13:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations for treatment-resistant depression (TRD) from 10:00-11:30 am ET on January 7th. “PTSD is one of the most challenging mental health conditions, with approximately 13 million adults in the U.S. living with persistent symptoms and limited treatment options,” said Dr. Guy Goodwin, Chief Medical Officer at Compass Pathways. “We are pleased to advance our clinical development - the unmet need is profound, and it demands bold innovation. We believe COMP360 has the potential to tra
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 12:07:00 EET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 10:00:00 EET | Press release
I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that underpin public safety, mobility and economic activity. Ramudden operates in markets where demand is steady and growing and benefits from deep commerci
RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 10:00:00 EET | Press release
RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
